重药控股：关于下属子公司调整担保额度的公告

Core Points - Chongqing Pharmaceutical (Group) Co., Ltd. has announced a total bank financing credit application of up to RMB 116.3 million for 40 wholly-owned subsidiaries for the year 2025 [2] - The company has also provided a maximum joint liability guarantee of up to RMB 614.836 million for 58 controlled subsidiaries for the same period [2] - An adjustment of guarantee limits for 8 subsidiaries has been proposed, resulting in a total reduction of RMB 18.9 million [2] - The actual credit limits and terms will be subject to approval by banks and financial institutions [2] - The board of directors has approved the adjustment proposal, which will be submitted for shareholder meeting review [2]